2.3 C
London
Friday, November 22, 2024
HomeTagsEisai

Tag: Eisai

spot_imgspot_img

Japan – Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Co., Ltd. and Biogen Inc. announced today a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP)...

Japan – Eisai Completes Rolling Submission to US FDA for LEQEMBI(R) (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early...

Eisai Co., Ltd.  and Biogen Inc. announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S....

Japan – Eisai Commences Business Activities At New Pharma Sales Subsidiary In Saudi Arabia

Eisai Commences Business Activities At New Pharma Sales Subsidiary In Saudi ArabiaEisai Co., Ltd. announced today that fully-fledged operations and business activities have begun...

Japan – Eisai Announces Status Relating to Acquisition of Own Shares

Eisai Co., Ltd. announced today that it has acquired its own shares based on Article 40 of its Articles of Incorporation pursuant to the...

Japan – Eisai Named to List of The Time 100 Most Influential Companies

TIME reveals the TIME100 Most Influential Companies list, highlighting companies making an extraordinary impact around the world. To assemble the list, TIME solicited nominations...

Japan – Eisai Strengthens Venture Investment Business Aimed at Accelerating Drug Discovery Innovation and Establishment of Ecosystem Platform

Eisai Co., Ltd. announced today that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim...

Japan – Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024

Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024 ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img